Preliminary reliability of the FACT-RNT in standard-of-care Lu-PSMA therapy of metastatic castration-resistant prostate cancer.

被引:0
|
作者
Gudenkauf, Lisa Marie
Murthy, Vishnu
Lam, Ethan C.
Li, Xiaoyin
Gardner, Linda
Tagawa, Scott T.
Dicker, Adam P.
Cella, David
Czernin, Johannes
Calais, Jeremie
Gonzalez, Brian D.
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ Calif Los Angeles, Mt House, CA USA
[3] Univ Calif Los Angeles, Ahmanson Translat Theranost Div, Los Angeles, CA USA
[4] Univ Calif Los Angeles, Los Angeles, CA USA
[5] New York Presbyterian Hosp, Div Hematol & Med Oncol, Weill Cornell Med, New York, NY USA
[6] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA USA
[7] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA
[8] Univ Calif Los Angeles, Dept Nucl Med, Los Angeles, CA USA
关键词
261-492-199; 130-3426-3529; 261-492-6491; 283-2494-5577-2829-12292; 261-436; 2;
D O I
10.1200/JCO.2024.42.4_suppl.99
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Clinical protocols to monitor efficacy of [177Lu]Lu-PSMA radiopharmaceutical therapy in metastatic castration-resistant prostate cancer.
    Unterrainer, Lena
    De Leiris, Nicolas
    Unterrainer, Marcus
    Ilhan, Harun
    Delker, Astrid
    Hempel, Linus
    Ells, Zachary
    Zahner, Joseph
    Holzgreve, Adrien
    Zacherl, Mathias J.
    Casuscelli, Jozefina
    Kiraz, Kevin
    Leenhardt, Julien
    Jacquet, Emmanuelle
    Long, Jerome
    Laramas, Mathieu
    Paller, Channing Judith
    Solnes, Lilja B.
    Gafita, Andrei
    Djaileb, Loic
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL) : 39 - 39
  • [2] 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
    Sanli, Yasemin
    Simsek, Duygu Has
    Sanli, Oner
    Subramaniam, Rathan M.
    Kendi, Ayse Tuba
    BIOMEDICINES, 2021, 9 (04)
  • [3] Efficacy of systemic therapy following [177Lu] Lu-PSMA in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
    Kostos, Louise Kathleen
    Lai, William Yu Ching
    Lambroglou, Peter
    Medhurst, Elizabeth
    Buteau, James Patrick
    Sandhu, Shahneen
    Tran, Ben
    Spain, Lavinia Anne
    Conduit, Ciara
    Wallace, Roslyn
    Alipour, Ramin
    Akhurst, Timothy J.
    Kong, Grace
    Cardin, Anthony
    Saghebi, Javad
    Kumar, Aravind Ravi
    Hofman, Michael S.
    Azad, Arun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [4] Perspective on 177Lu-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer
    Kwekkeboom, Dik
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (07) : 1002 - 1003
  • [5] Lu-PSMA-617 for metastatic castration-resistant Prostate Cancer
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2022, 53 (02) : 106 - 106
  • [6] Response to [177Lu]Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer patients presenting with only lymph node metastases
    Zisser, Lucia
    Yu, Josef
    Oszwald, Andre
    Wollenweber, Tim
    Kretschmer-Chott, Elisabeth
    Grubmueller, Bernhard
    Kramer, Gero
    Shariat, Shahrokh F.
    Mitterhauser, Markus
    Vraka, Chrysoula
    Hacker, Marcus
    Haug, Alexander R.
    Rasul, Sazan
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (11) : 1113 - 1120
  • [7] 177Lu-PSMA-617 Therapy in a Case of Metastatic Castration-Resistant Prostate Cancer
    Qu, Gengcuo
    Hua, Qingchu
    Li, Hongmei
    Zhang, Yu
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (02) : 152 - 153
  • [8] High Activity 177Lu-PSMA Therapy Of Metastatic Castration-resistant Prostate Cancer
    Happel, C.
    Kranert, W. T.
    Bockisch, B.
    Groener, D.
    Davis, K. H.
    Wichert, J.
    Stefanova, M.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S647 - S648
  • [9] RECIP 1.0 Predicts Progression-Free Survival After [ 177 Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
    Gafita, Andrei
    Djaileb, Loic
    Rauscher, Isabel
    Fendler, Wolfgang P.
    Hadaschik, Boris
    Rowe, Steven P.
    Herrmann, Ken
    Solnes, Lilja B.
    Calais, Jeremie
    Rettig, Matthew B.
    Weber, Manuel
    Farolfi, Andrea
    Benz, Matthias R.
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (06) : 917 - 922
  • [10] Lu-177 PSMA Radioligand Therapy as Salvage Treatment in Metastatic Castration-Resistant Prostate Cancer
    Kulkarni, H. R.
    Singh, A.
    Schuchardt, C.
    Langbein, T.
    Zhang, J.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S287 - S288